BioCentury
ARTICLE | Emerging Company Profile

Platelet portrait

How thromboDx's platelet-based test could compete with other cancer Dx

February 15, 2016 8:00 AM UTC

thromboDx B.V. has found a new repository to mine for disease diagnosis and treatment response: platelets. The company's most advanced programs are for cancer, where the technology could be easier to use and provide a more comprehensive assessment than tissue or blood-based tests.

Platelets are found in the tumor microenvironment and guard tumor cells from immune elimination. ...